StockData
Attovia Therapeutics, Inc. logo

Attovia Therapeutics, Inc. (ATTO) stock

ATTONasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 9, 2026
$15.13−0.68 (-4.30%)

Close on Nov 13, 2026Market cap $690.70MP/E –Yield –

Attovia Therapeutics statistics

37 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings
–
Last ex-dividend date
No dividends
Fundamentals through
Sep 30, 2026
Share price as of
Nov 13, 2026

Valuation ratiosIndustry

Market Cap
$690.70M
$272.32M
Enterprise Value
$294.77M
$146.23M
PB Ratio
1.74
2.00
P/TBV Ratio
1.74
2.22

Share statisticsIndustry

Shares Change (QoQ)
908.7%
0.50%
Float
26M
49M
Shares Held by Insiders
43.1%
11.7%

Short sellingIndustry

Short Interest
2M
–
Short Interest Change
9.25%
-0.80%
Short % of Float
6.12%
9.01%
Short % of Shares Outstanding
3.48%
6.30%
Days to Cover
4.50
5.15

Stock price statisticsIndustry

20-Day Moving Average
$15.10
–
50-Day Moving Average
$17.53
–
Average True Range (14)
$1.51
–
Price Change (1 Week)
-0.92%
-1.15%
Price Change (1 Month)
2.37%
-4.87%
Price Change (3 Months)
-33.4%
-21.0%
Price Change (3 Years)
3119.2%
-29.5%
Price Change (5 Years)
-43.1%
-77.9%
Price Change (10 Years)
84.5%
-65.4%
Average Volume (10 Days)
243,966
–
Average Volume (20 Days)
269,970
–
Average Volume (90 Days)
406,611
–
Relative Volume
0.79
0.70
Relative Strength Index (14)
44.3
43.4

Financial positionIndustry

Current Ratio
34.66
3.30
Quick Ratio
33.92
2.39

Balance sheetIndustry

Net Cash (Debt)
$395.94M
$17.76M
Net Cash Per Share
$8.67
$0.80
Equity (Book Value)
$397.74M
$53.89M
Book Value Per Share
$8.71
$1.50
Tangible Book Value
$397.74M
$27.13M
Working Capital
$392.85M
$79.99M

Scores and fair valueIndustry

Altman Z-Score
29.98
0.23

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Nov 13, 2026. The S&P 500 is measured by the SPY fund.

PeriodATTOS&P 500DifferenceATTO per yearS&P 500 per year
1 month+2.8%-3.0%+5.8 pts
3 months-21.1%-2.8%−18.3 pts
Year to date+3119.1%+11.5%+3107.7 pts
1 year+3119.1%+13.5%+3105.7 pts
3 years+3119.1%+77.7%+3041.4 pts+218.1%+21.1%
5 years-43.1%+72.6%−115.7 pts-10.7%+11.5%
10 years+77.0%+308.2%−231.2 pts+5.9%+15.1%

Short interest

Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.

2M ATTO shares were sold short on Oct 30, 2026, up 9.3% from the previous report, or 6.12% of the shares available to trade. At recent volumes it would take 4.5 days to buy them back. Over the last 20 sessions, 50.3% of the volume reported to FINRA was short selling.

Settlement dateShares shortChangeAvg. daily volumeDays to cover
Oct 30, 20261,587,537+9.3%352,5554.5
Oct 15, 20261,453,089-11.9%416,5273.5
Sep 30, 20261,649,612+98.5%553,8413.0
Sep 15, 2026831,090+28.1%207,2024.0
Aug 31, 2026648,541+26.7%212,0753.1
Aug 14, 2026511,865–732,9251.0
Jul 14, 202376,012-31.4%553,2981.0
Jun 30, 2023110,879+14.1%98,7841.1
Jun 15, 202397,144-34.1%504,4571.0
May 31, 2023147,493+9205.6%4,789,8621.0
May 15, 20231,585-62.5%20,7421.0
Apr 28, 20234,227+4.5%3,2301.3

Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.

See a number that looks wrong?